Morphosys Ag (MOR.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -326 | 5,886 | -3,735 | -2,094 | 468 |
| Other Working Capital | 22,947 | 17,318 | 3,324 | -2,832 | 13,319 |
| Other Operating Activity | -7,137 | -10,142 | -3,520 | 1,255 | -5,493 |
| Operating Cash Flow | $15,484 | $13,063 | $-3,932 | $-3,671 | $8,294 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -302 | -637 | -1,050 | -961 | -409 |
| Purchase Of Investment | -12,795 | -7,989 | -798 | 0 | -10,989 |
| Sale Of Investment | 6,217 | 0 | 812 | 6,556 | 1,510 |
| Purchase Sale Intangibles | -10,617 | -376 | -256 | -616 | -228 |
| Investing Cash Flow | $-17,496 | $-9,002 | $-1,292 | $4,978 | $-10,116 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 230 | N/A | 930 | 0 |
| Other Financing Activity | -6 | -176 | 539 | -31 | 33 |
| Financing Cash Flow | $-6 | $54 | $539 | $899 | $33 |
| Exchange Rate Effect | 130 | -21 | -18 | -28 | 154 |
| Beginning Cash Position | 45,349 | 41,255 | 45,958 | 43,780 | 45,414 |
| End Cash Position | 43,461 | 45,349 | 41,255 | 45,958 | 43,780 |
| Net Cash Flow | $-2,018 | $4,115 | $-4,685 | $2,206 | $-1,788 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,484 | 13,063 | -3,932 | -3,671 | 8,294 |
| Capital Expenditure | -10,918 | -1,013 | -1,312 | -1,577 | -637 |
| Free Cash Flow | 4,566 | 12,050 | -5,244 | -5,249 | 7,657 |